MicroChips' first trial will evaluate whether one implanted device, installed during a simple outpatientoperation, can replace a year of daily injections of a generic version of Eli Lilly's bone-building osteoporosis drug Forteo, or parathyroid hormone.
Two years later the hospital president realized his mistake and brought in a new director (one with managerial experience) for the outpatient clinics, who quickly streamlined the structure and brought the operation under control.